The 2nd International Conference on Microbiology and One Health (MOH-VN 2024) took place in Quy Nhon City, Vietnam, from August 11th – 14th, 2024. Following the success of the 1st MOH-VN 2018, MOH-VN 2024 included 45 talks and 29 posters with six different divisions that span various aspects of microbiology. Key topics include early diagnostics, antimicrobial resistance, vaccine development, pathogenesis, drug discovery, bioinformatics, zoonosis, and environmental microbiology. Co-organized by the International Center for Interdisciplinary Science and Education, Center for Bioscience and Biotechnology, and Oxford University linical Research Unit in Vietnam, MOH-VN 2024 aimed to provide an international forum for scientists, researchers, and medical professionals to discuss microbiology and One Health, promoting scientific collaboration.  See more at MOH-VN 2024’s Website

Assoc. Prof. Dr. Nguyen Thi Thu Hoai – Vice Director of RCID is a member of the MOH-VN 2024 organizing committee and also a speaker in the event. The title of her talk was Pseudomonas aeruginosa: colonisation and antimicrobial resistance development

Abstract

Pseudomonas aeruginosa (P. aeruginosa) is a ubiquitous bacterium which can be found in most moisture places such as soil, water, food, plants, and animals including humans. This Gram-negative, rod-shaped, asporogenous, mono-flagellated microorganism has an extensively large and plastic genome which allows it to adapt effectively to surrounding environments. It is also a prevalent cause of nosocomial infections, contributing to high morbidity and mortality rates. In clinical settings, P. aeruginosa isolates have been documented to exhibit resistance to nearly all classes of commonly used antibiotics, including aminoglycosides, cephalosporins, fluoroquinolones, and carbapenems. In our research group, we investigated the presence of P. aeruginosa in humans and the environment as well as the biological characteristics of the isolates, their impact on diseases, and their plastic response to antibiotics. For this talk, a review of the current understanding of P. aeruginosa in the view of one health is provided. Furthermore, the contribution of our research group in this field is also present. There is no doubt that understanding this pathogen will help us get closer to effectively interfering with its pathogenesis and antibiotic resistance, which is an ever-challenging problem for public health